col-144 and Substance-Related-Disorders

col-144 has been researched along with Substance-Related-Disorders* in 1 studies

Trials

1 trial(s) available for col-144 and Substance-Related-Disorders

Article	Year
Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study. Journal of clinical pharmacology, 2020, Volume: 60, Issue:4 Lasmiditan is a centrally penetrant, highly selective 5-hydroxytryptamine (serotonin) receptor 1F (5HT Topics: Administration, Oral; Adolescent; Adult; Alprazolam; Benzamides; Cross-Over Studies; Female; Healthy Volunteers; Humans; Male; Middle Aged; Piperidines; Pyridines; Recreational Drug Use; Risk Assessment; Serotonin Receptor Agonists; Substance-Related Disorders; Young Adult	2020

Article

Year

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study.

Journal of clinical pharmacology, 2020, Volume: 60, Issue:4

Lasmiditan is a centrally penetrant, highly selective 5-hydroxytryptamine (serotonin) receptor 1F (5HT

Topics: Administration, Oral; Adolescent; Adult; Alprazolam; Benzamides; Cross-Over Studies; Female; Healthy Volunteers; Humans; Male; Middle Aged; Piperidines; Pyridines; Recreational Drug Use; Risk Assessment; Serotonin Receptor Agonists; Substance-Related Disorders; Young Adult

2020